INmune Bio Inc. logo

INmune Bio Inc.

INMB | NASDAQ
Chart Builder DCF Calculator
$2.29
-$0.04 (-1.72%)
At close: Sep 21, 2026, 4:00 PM ET
$2.38
+$0.09 (+3.93%)
Pre-market: Sep 22, 2026, 7:37 AM ET

Market Data

Market Cap
$60.88M
Enterprise Value
$43.87M
Beta
0.94
Average Volume
636.71K
Shares Outstanding (Diluted)
26.72M
Shares Change YoY
14.68%
Institutional Ownership
20.23%
Exchange
NASDAQ
ISIN
US45782T1051

Price Performance

Price Change 1M
0.4%
Price Change 3M
61.3%
Price Change 6M
87.7%
Price Change YTD
48.7%
Price Change 1Y
15.7%
Price Change 3Y
-66.7%
Price Change 5Y
-88.6%
1M CAGR (ann.)
9.6%
1Y CAGR (ann.)
16.2%
5Y CAGR (ann.)
-34.7%
All-Time CAGR
-15.1%

Valuation

PE Ratio
-3.32
Forward PE
N/A
PEG Ratio
-0.03
Forward PEG
-0.08
PS Ratio
N/A
Forward PS
6.40
PB Ratio
2.99
P/FCF Ratio
-3.09
P/Adj. FCF Ratio
-2.98
P/OCF Ratio
-4.09
EV/Sales
N/A
EV/EBIT
-2.56
EV/EBITDA
-2.37
EV/FCF
-2.23
Earnings Yield
-30.1%
FCF Yield
-32.4%
Adj. FCF Yield
-33.6%

Financial Health

Net Cash
$17.01M
Total Debt
$1.41M
Cash & Short-Term Investments
$18.41M
Total Assets
$26.85M
Current Ratio
4.04
Quick Ratio
4.04
Debt / Equity Ratio
0.07
Debt / EBITDA
-0.08
Debt / FCF
-0.07
OCF / Debt
-13.08
Interest Coverage
0.00
Altman Z-Score
-6.92
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-3.8%

Returns

Return on Assets
-68.6%
Return on Equity
-82.9%
Return on Invested Capital
-92.8%
Return on Capital Employed
-96.4%
Return on Tangible Assets
-68.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-94.4%
Revenue CAGR 5Y
-61.1%
Revenue CAGR 10Y
20.2%
EPS CAGR 3Y
39.2%
EPS CAGR 5Y
8.7%
EPS CAGR 10Y
-17.9%
FCF CAGR 3Y
6.6%
FCF CAGR 5Y
1.6%
FCF CAGR 10Y
-22.8%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
71.0%
Revenue Growth Next 3Y
N/A
Earnings Date
Oct 28, 2026
EPS Estimate (next Q)
-$0.15
EPS Growth Est (next Q)
-38.9%
Revenue Est (next Q)
$1.88M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$22
Price Target Upside
860.7%

Cash Flow

Operating Cash Flow
$-18.38M
Free Cash Flow
$-19.7M
Adj. Free Cash Flow
$-20.45M
FCF Per Share
-$0.61
OCF Per Share
-$0.56
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-108K
Operating Income
$-20.2M
EBITDA
$-18.51M
Net Income
$-18.42M
EPS (Diluted)
-$0.69
Revenue / Employee
N/A
Profit / Employee
$-876.95K
Employees
21

© 2026 bestshares.com. All rights reserved.